CAHmelia-204 Study of 200mg Once-Daily (QD) Tildacerfont in Adult Congenital Adrenal Hyperplasia (CAH) Did Not Achieve Primary Endpoint of Glucocorticoid (GC) Reduction Dose-Ranging Data from CAHptain ...

Management of classic congenital adrenal hyperplasia (CAH) can be a lifelong balancing act, but the most feared life-threatening complication is an acute adrenal insufficiency, also known as an ...

For patients living with congenital adrenal hyperplasia (CAH) — a rare genetic disease marked by the inability to produce cortisol — it’s often a balancing act when it comes to treatment options along ...

Missed or delayed diagnosis of classical congenital adrenal hyperplasia (CAH) is associated with salt-wasting crisis and significant neonatal morbidity and mortality. Newborn screening (NBS) programs ...

Cortisol insufficiency, present in all types of congenital adrenal hyperplasia (CAH), may manifest as hyperpigmentation, vomiting or a potentially life-threatening adrenal crisis, presenting with ...

WALLINGFORD – At times, it's difficult for Faith Colello to accept that she is not like everyone else. And it’s true. Colello, a 22-year-old Wallingford resident, is unusual. She taught herself five ...

BOSTON -- Investigational crinecerfont reduced the need for glucocorticoids in adults and kids with congenital adrenal hyperplasia (CAH), two phase III trials found. In the adult trial of 182 patients ...

Method Solid Phase Two-Site Fluoroimmunometric Assay. CPT Code 83516 Testing Scope Detection of elevated levels of 17 α-OH-progesterone from clinical specimens. Preferred Specimen Heel stick dried ...

Shares of Crinetics Pharmaceuticals (NASDAQ:CRNX) traded sharply lower after the company posted initial data from a Phase 2 trial for atumelnant, its experimental therapy for congenital adrenal ...

CAHmelia-203 Study of Tildacerfont in Adult Classic Congenital Adrenal Hyperplasia (CAH) with Severe Hyperandrogenemia Did Not Meet Primary Efficacy Endpoint Positive Data from CAHptain-205 Study of ...